TABLE 2.
Related Medical Outcomes for Single-substance Benzonatate Exposure Cases in Children 0 to 16 Years Old, NPDS 2010 to 2018
| Age Group |
||||
|---|---|---|---|---|
| Related Medical Outcomesa,b | 0–5 | 6–9 | 10–16 | Subtotal |
|
| ||||
| Unintentional, total n (%) | 2718 (82.9) | 260 (7.9) | 299 (9.1) | 3277 |
| No effect | 1492 (82.2) | 85 (72.6) | 59 (45.7) | 1636 (79.3) |
| Minor effect | 274 (15.1) | 31 (26.5) | 62 (48.1) | 367 (17.8) |
| Moderate effect | 39 (2.1) | 1 (0.9) | 8 (6.2) | 48 (2.3) |
| Major effect | 8 (0.4) | — | — | 8 (0.4) |
| Death | 3 (0.2) | — | — | 3 (0.1) |
| Intentional, misuse, or abuse, total n (%) | 6 (8.1) | 30 (40.5) | 38 (51.4) | 74 |
| No effect | 4 (80.0) | 13 (76.5) | 14 (56.0) | 31 (66.0) |
| Minor effect | 1 (20.0) | 3 (17.6) | 6 (24.0) | 10 (21.3) |
| Moderate effect | — | 1 (5.9) | 5 (20.0) | 6 (12.8) |
| Major effect | — | — | — | — |
| Death | — | — | — | — |
| Intentional or suspected suicides, total n (%) | 0 (0.0) | 2 (0.7) | 302 (99.3) | 304 |
| No effect | — | 1 (50.0) | 120 (48.2) | 121 (48.2) |
| Minor effect | — | 1 (50.0) | 74 (29.7) | 75 (29.9) |
| Moderate effect | — | — | 40 (16.1) | 40 (15.9) |
| Major effect | — | — | 13 (5.2) | 13 (5.2) |
| Death | — | — | 2 (0.8) | 2 (0.8) |
—, no data available.
a
Medical outcomes among individuals with a related clinical effect, excluding unrelated medical outcomes, cases not followed, unable to follow, and confirmed non-exposures.
b
Related clinical effect cannot be mapped to specific drug in multiple-substance exposure.